Shop Till Medical Costs Drop

In an effort to bring down the costs of medical care, the Trump administration wants to make prices visible to patients, and it's moving aggressively to make that happen.
 Last year President Trump signed a legal requirement barring pharmacy gag clauses under Medicare Part D plans. Those clauses prohibited pharmacists from volunteering that a medication may be less expensive than an insurance copay if purchased for cash—as was the case more than 20% of the time.

Ebola Case Appears in Uganda As Congo Outbreak Spreads

KAMPALA, Uganda—The deadly Ebola outbreak that has been raging in the Democratic Republic of Congo for more than 10 months has crossed into neighboring Uganda, where authorities on Tuesday said a 5-year-old boy tested positive for the hemorrhagic fever.
 The spread of the disease across the border is a major setback for local and international health officials who have failed to contain the Ebola outbreak in Congo's Ituri and North Kivu provinces, the world's first

Missouri Abortion Clinic Will Stay Open

A St. Louis circuit judge ruled Missouri's only abortion clinic will stay open for now, a decision that temporarily keeps the state from becoming the only one in the U.S. without an operating abortion clinic.
 The decision comes amid a flurry of abortion-related legislation in states, including Missouri, where lawmakers last month voted to prohibit abortion, except in emergency, after eight weeks of pregnancy.
 Circuit Judge Michael Stelzer on Monday granted a preliminary injunction for the Reproductive Health Services of Planned Parenthood of the St. Louis Region, and ordered the state's Department of Health and

Zolgensma, Priciest Medicine Approved

The world's most expensive medicine is about to hit the market. A one-time treatment for a devastating infant muscle-wasting disease won approval from the U.S. Food and Drug Administration Friday. Its maker Novartis AG says the gene therapy will cost $2.125 million.
 The therapy, called Zolgensma, treats an inherited disease called spinal muscular atrophy, or SMA, whose victims typically die before the age of two if untreated. It is the latest gene therapy—a technique that

White House Targets Health Costs

President Trump is expected to release an executive order as early as next week to mandate the disclosure of prices in the health-care industry, according to people familiar with the discussion.
 The order could direct federal agencies to pursue actions to force a host of players in the industry to divulge cost data, the people said. The administration is also looking at using agencies such as the Justice Department to tackle regional monopolies of hospitals and health-insurance plans over concerns they are driving up the cost of care, according to two people familiar with the discussions.

Hospital App Alerts On Deadly Condition

The Montefiore Health System and its affiliated medical school are using artificial intelligence to better predict a common emergency among patients in their care, among other conditions.
 The first application focused on using AI to predict which patients will develop respiratory failure that requires mechanical ventilation, a project that has so far yielded better results than traditional alerting systems.

Drugmaker's Stock Tumbles Amid Dispute Over Rebates

Mallinckrodt PLC lost nearly one-quarter of its stock-market value Tuesday after the drugmaker said a dispute with health regulators might cost it hundreds of millions of dollars and reduce future sales for one of its top selling products.
 The company said the Centers for Medicare and Medicaid Services has determined it has to pay additional money to states related to Acthar, an injected product used to treat multiple sclerosis, infantile

Measles Spreads at Slower Rate

 The number of new U.S. measles cases continued to grow last week but at a slower pace, with the total now at 880 in 24 states so far this year, the Centers for Disease Control and Prevention reported Monday.
 That is 41 more cases than a week ago, and included one additional state, Oklahoma, where a person contracted the measles after traveling domestically and internationally.

States File More Suits Targeting OxyContin

 Six more states launched legal actions against Purdue Pharma LP this week, ramping up pressure on the OxyContin maker to contain mounting liability over its alleged role in fueling the opioid epidemic.
 Attorneys general in Kansas, Iowa, Maryland, West Virginia and Wisconsin each announced actions Thursday. The moves follow a joint investigation by the states dating back to 2017.
 Pennsylvania launched its own lawsuit against Purdue earlier this week.

N.Y's First Proton Therapy Center Set to Open

New York City is set to get a new radiation-treatment center, nearly a decade in the making, that uses proton beams to treat cancerous tumors. Called the New York Proton Center, it is a for-profit partnership of Memorial Sloan Kettering Cancer Center, Montefiore Health System and Mount Sinai Health System, managed by the ProHEALTH company. Financing for the center was provided in part by the hospitals.
 It will be the first such proton therapy facility in New York state when it starts treating patients in July. It was slated to begin treating patients in 2018 and initially set to cost $300 million. Charles Simone, chief